Engineering the Next Generation of Neurotherapeutics.
Integrating artificial intelligence, molecular therapeutics, cell engineering, and gene therapy to address complex diseases of the nervous system.
Intervening across the biology of neurological disease.
Neurological diseases emerge from complex interactions between molecular dysfunction, neuronal degeneration, and disruption of functional neural circuitry. NeuroSild is building an integrated therapeutic discovery platform designed to address disease across these biological scales.
AI-Powered Drug Discovery
Computational and structure-guided approaches for small-molecule and therapeutic peptide discovery.
Engineered Cell Therapy
Stem-cell engineering strategies designed to replace vulnerable neurons and rebuild functional circuitry.
Gene Therapy
Precision genetic medicines aimed at disease-driving mechanisms in rare neurological disorders.
Translational Neuroscience
Disease-relevant models connecting computational discovery with therapeutic validation.
From molecular dysfunction to circuit failure.
We pursue therapeutic strategies that can address disease at multiple levels—from molecular pathology and cellular stress to neuronal loss, disrupted connectivity, and functional decline.
Protect
Target mechanisms that drive neuronal stress, degeneration, inflammation, and loss of function.
Restore
Develop regenerative approaches intended to replace vulnerable or lost neuronal populations.
Rebuild
Engineer therapeutic systems designed to re-establish connectivity across damaged neural networks.
A multimodal therapeutic discovery engine.
AI-Powered Molecular Discovery
Our discovery workflow integrates disease biology, structural information, computational modeling, and experimental neuroscience to prioritize therapeutic opportunities and accelerate candidate generation.
Engineered Stem Cell Therapeutics
We are exploring neuronal replacement strategies designed not only to replace lost cells, but ultimately to reconstruct disease-relevant circuitry and restore functional connectivity.
Precision Gene Therapy
Our gene therapy research focuses on neurological diseases where correcting, replacing, silencing, or modulating disease-associated genes may provide durable therapeutic benefit.
A diversified portfolio in neurological disease.
Selected programs are shown at a high level while NeuroSild remains in stealth mode.
| Program | Disease Area | Modality | Stage |
|---|
Additional programs remain undisclosed.
Connect with NeuroSild.
We welcome inquiries related to scientific collaboration, technology and licensing, strategic partnerships, investment, and corporate development.
neurosildtherapeutics@gmail.com